April 26, 2017
California’s $3-billion bet on stem cells faces final test
news@nature.com - Fetched: April 26th, 2017, 10:00am UTC
Major investment in regenerative medicine enters its last stage — and the money might run out before treatments are ready.
Nature 544 401 doi: 10.1038/544401a